Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125623121 | 12562312 | 1 | I | 20160621 | 20160707 | 20160715 | 20160715 | EXP | CH-NAPPMUNDI-DEU-2016-0018139 | PURDUE | 65.00 | YR | F | Y | 0.00000 | 20160714 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125623121 | 12562312 | 1 | PS | OXYNORM Capsule | OXYCODONE HYDROCHLORIDE | 1 | Oral | 300 MG, SINGLE | Y | U | 91490 | 300 | MG | CAPSULE, HARD | |||||
| 125623121 | 12562312 | 2 | SS | ALCOHOL. | ALCOHOL | 1 | Unknown | 1-2DL | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125623121 | 12562312 | 1 | Musculoskeletal pain |
| 125623121 | 12562312 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125623121 | 12562312 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125623121 | 12562312 | Disturbance in attention | |
| 125623121 | 12562312 | Suicide attempt | |
| 125623121 | 12562312 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125623121 | 12562312 | 1 | 20160621 | 0 |